Category: Technology Licenses
Created On: 2022-04-28
Record Count: 12
- Health & Fitness
- Electro Medical/ Elector therapeutic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 372635
5,188,104 Treatment of Eating Disorders by Nerve Stimulation
5,231,988 Treatment of Endocrine Disorders by Nerve Stimulation
5,263,480 Treatment of Eating Disorders by Nerve Stimulation
5,540,730 Treatment of Motility Disorders by Nerve Stimulation
5,540,734 Cranial Nerve Stimulation Treatments Using Neurocybernetic Prosthesis
5,707,400 Treating Refractory Hypertension by Nerve Stimulation
20060247719 Weight Loss Method and Device
20060247721 Identification of Electrodes for Nerve Stimulation in the Treatment of Eating Disorders
20060247722 Noninvasively Adjustable Gastric Band
20070027483 Stimulating Cranial Nerve to Treat Disorders Associated with the Thyroid Gland
20070027484 Autonomic Nerve Stimulation to Treat a Pancreatic Disorder
20070027492 Autonomic Nerve Stimulation to Treat a Gastrointestinal Disorder
20070027498 Selective Nerve Stimulation for the Treatment of Eating Disorders
20070093870 Cranial Nerve Stimulation to Treat Eating Disorders
6,587,719 Treatment of Obesity by Bilateral Vagus Nerve Stimulation
6,609,025 Treatment of Obesity by Sub-Diaphragmatic Nerve Stimulation
7,299,091 Treatment of Obesity by Bilateral Vagus Nerve Stimulation
20040039427 Treatment of Obesity by Sub-Diaphragmatic Nerve Stimulation
â€œField of Useâ€ shall mean the treatment (including therapeutic or diagnostic) by means of a device that applies electrical signals directly or indirectly to the vagus, trigeminal or glossopharyngeal nerves i) for weight reduction, or ii) for hypertension or diabetes (including impaired fasting glycaemia, impaired glucose tolerance or insulin resistance) in patients having a body mass index of 25 or more.
IPSCIO Record ID: 275818
The vagus nerve, historically cited as the pneumogastric nerve, is the tenth cranial nerve or CN X, and interfaces with the parasympathetic control of the heart, lungs, and digestive tract. The vagus nerves are paired but are normally referred to in the singular.
Licensed Patents means the NS, the Feinstein Institute for Medical Research, formerly known as North Shore Long Island Jewish Research Institute licensed Patents.
The patents include Inhibition of Inflammatory Cytokine Production by Stimulation of Brain Muscarinic Receptors, and, Cholinergic Agonists and Vagus Nerve Stimulation, and, Neural Tourniquet.
Vagus nerve stimulation is a medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an add-on treatment for certain types of intractable epilepsy and treatment-resistant depression. Frequent side effects include coughing and shortness of breath.
IPSCIO Record ID: 375
Licensor owns a patent relating to Neurocyberenetic Prosthesis Technology (U.S. Patent No. 4,702,254) and other pending patent applications and know-how, and technology relating thereto (collectively referred to as the â€œTechnologyâ€).
Oct. 27, 1987
Sept. 19, 1989
JuneÂ 25, 1991
MarchÂ 3, 1989
SeptemberÂ 12, 1989
SeptemberÂ 5, 1990
Austria, Belgium, Switzerland, Germany, France, United
Kingdom, Liechtenstein, Luxembourg, Netherlands, Sweden
SeptemberÂ 11, 1984
IPSCIO Record ID: 3613
IPSCIO Record ID: 4588
The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (â€œTNSâ€). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
The present disclosure generally relates to implantable neurostimulator systems, devices and methods of using the same and more particularly relates to implantable neurostimulator systems, devices and methods including at least one implantable electrode for treating neuropsychiatric disorders by stimulating superficial, cutaneous elements of cranial nerve(s).
IPSCIO Record ID: 4554
The intellectual property relates to the PoNSTM device. The Patent Rights include one XYZ claim and 22 method claims, which cover a device in the form of a mouth piece that non-invasively delivers neurostimulation to the brain stem via the trigeminal nerve.
The intellectual property relating to the PoNSTM device is the subject of U.S. Patent Application 12/348301 and Provisional Patent Application 61/019,061. (Information on the patent applications was not available from the U.S. Patent and Trademark office.)
The device is held lightly in place by the lips and teeth around the neck of the tab that goes into the mouth and rests on the anterior, superior part of the tongue. The paddle-shaped tab of the device has a hexagonally patterned array of 143 gold-plated circular electrodes (1.50 mm diameter, on 2.34 mm centers) that is created by a photolithographic process used to make printed circuit boards. It uses low-level electrical current to stimulate the lingual branch projections of at least two cranial nerves in the anterior tongue through the gold-plated electrodes.
The brain's ability to recognize its operation in response to new information sources, new functional needs, or new communication pathways is referred to as neuroplasticity. Neuroplasticity is a process underlying all cerebral learning, training, and rehabilitation. Neuromodulation is the use of external tactile stimulation to intentionally change and regulate the internal electrochemical environment of the brain. Traditional rehabilitation interventions have typically involved medication and various forms of therapies, including physical therapy. The PoNSTM device is being investigated in combination with physical therapy for the treatment of neurological symptoms from disease and trauma including traumatic brain injury (TBI) and Multiple Sclerosis. The patent is pending on the device.
IPSCIO Record ID: 250719
Licensed Products are worldwide for the treatment of (i) chronic pain in humans through the application of electrical energy to the nervous system, (ii) inflammatory conditions of the human body through the application of electrical energy to the vagus nerve, a nerve that interfaces with parasympathetic control of the heart, lungs and digestive tract and (iii) urinary and fecal dysfunction in humans through the application of electrical energy anywhere in or on the human body, excluding, in each case, any product or method that involves the placement of electrodes or the administration of electrical stimulation inside the cranial cavity or to the ocular nervous system or the auditory nervous system.
â€œEpioneâ€ means the Epione implantable pulse generator, leads, external pulse generator, charging system and related system components and software
â€œExternalsâ€ means any peripheral or auxiliary device that can be used in connection with, or operate in concert with, Epione, including the components that when assembled comprise such device, and including surgical procedure tools, protection apparatus, controllers, battery chargers, patient remote controller, programmer, software and electrodes.
IPSCIO Record ID: 27500
The University's hereby grants to Licensee a non-exclusive license (the 'Copyright License') under Regents' Copyright Rights, in jurisdictions where the University's Copyright Rights exist, to use, produce, copy, reproduce, display, create derivative works of, perform, and distribute the Licensed Copyright Products in the Field of Use to the extent permitted by law.
The University's grants to Licensee the right to sublicense the University's Patent Rights granted to Licensee.
Head Pain Management. The other innovation consists of technology designed to take advantage of the fact that stimulating the sensory fibers of a nerve can mask pain perception. The technology uses mechanical vibration (as opposed to electrical stimulation) to stimulate such fibers and is non-invasive and patient controllable. The target market for the commercialization of this technology would include migraine sufferers; those with trigeminal neuropathy, a debilitating, long-lasting oral pain, often arising from failed or compromised dental procedures; and others.
Provisional Patent Application No. 61/905,616 entitled, 'Device, System and Method for Reducing Headache Pain,' filed November 18th, 2013
â€œCopyright Graphical User Interface Software to Control and Monitor Nerve Stimulation Device'
IPSCIO Record ID: 384872
Transcutaneous electrical nerve stimulation (TENS) is a Non-invasive approach achieving limited efficacy in practice due to power limitations, inadequate dosing and low patient adherence.
IPSCIO Record ID: 26559
The Urgent PC Neuromodulation System uses percutaneous tibial nerve stimulation (PTNS) to treat overactive bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence.
The Urgent PC neuromodulation system is a minimally invasive device designed for office-based treatment of overactive bladder symptoms of urge incontinence, urinary urgency and urinary frequency. This product uses percutaneous tibial nerve stimulation to deliver an electrical pulse that travels to the sacral nerve plexus, a control center for bladder function.
IPSCIO Record ID: 28986
The agreement also includes a non-exclusive license to the copyright over certain user interface software for controlling and monitoring nerve stimulation. The agreement allows for sublicensing.
Sleep Disorders. One innovation consists of technology designed to take advantage of the fact that signals from the limbs interpreted by the brain as movement can elicit enhanced breathing rates. The device we would expect to develop would use a nerve stimulation technique to enhance the breathing rate without actual limb movement. The target market for the commercialization of this technology would include people who suffer sleep disorders mostly due to irregular breathing, the most common of which is sleep apnea.
Provisional Patent Application No. 61/856,883 entitled, 'Device, System and Method for Facilitating Breathing Via Stimulation of Limb Movement'
Patent Cooperation Treaty Application No. PCT/US14/047642 entitled, 'Device, System and Method for Facilitating Breathing Via Simulation of Limb Movement'
â€œCopyright Graphical User Interface Software to Control and Monitor Nerve Stimulation Device'
IPSCIO Record ID: 275838
Oscillating Field Stimulation (OFS)
Oscillating Field Stimulation and a Growth Factor
Hydralazine + PEG
PEG for Vascular Leakage
Double Sucrose Gap Recording Apparatus
Coherent Anti-Stokes Raman Scattering
Licensed Patents shall mean
4,919,140 – Method and apparatus for regenerating nerves
OFS + Inosine Technology means the technology No 62139, US Patent Application No. 10/748,572 and /or PT Patent Application No. PCT/US2003/01480.